An interventional study of Nordic Hamstring Exercise Training and Custom Foot Orthoses and Exercise Therapy in Hamstring Muscle Strain, Adult Acquired Flatfoot Deformity and Ulnar Collateral Ligament Sprain After Reconstruction, sponsored by National Taiwan University Hospital. Not yet recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to investigate the correlations between dynamic soft tissue displacement, mechanical properties, and functional recovery across three studies: biceps femoris long head (BFlh) muscle injury, adult acquired flatfoot deformity (AAFD), and medial ulnar collateral ligament anterior bundle (mUCLAB) reconstruction. The main questions it aims to answer are:
Researchers will compare biomechanical and functional outcomes within participants before and after each intervention, as well as against comparison groups (athletes with full return-to-sport clearance or asymptomatic flatfoot adults), using UST algorithms and SWE. Depending on their allocated cohort, participants will:
Part 1 (Hamstring Muscle Injury):
Part 2 (Adult Acquired Flatfoot Deformity):
Part 3 (Elbow Ligament Reconstruction Cohort):
171 studies on the registry are indexed under Flatfoot; 42 are open to participants now.
This study's planned enrollment of 80 is above the median of 37 across 124 interventional studies indexed under Flatfoot.
Browse Flatfoot studies →National Taiwan University Hospital is the lead sponsor of 2,608 studies on the registry; 573 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.
Counted across the registry records on this site, refreshed daily.
Part 1
Inclusion Criteria:
Exclusion Criteria:
Part 2
Inclusion Criteria:
Exclusion Criteria:
Part 3
Inclusion Criteria:
Exclusion Criteria:
Athletes within 6 months of a unilateral biceps femoris long head (BFlh) muscle injury who have returned to the team but cannot fully participate in high-intensity training or competition. Participants complete an 8-week progressive Nordic hamstring exercise program (twice weekly, progressing from 3 sets of 6 to 3 sets of 12 repetitions) to evaluate changes in muscle displacement and eccentric knee flexor strength.
Behavioral: Nordic Hamstring Exercise Training
Adults aged 18-80 years diagnosed with symptomatic flexible flatfoot (FPI-6 score \>= 6 or navicular drop \> 9 mm). Participants undergo 6 weeks of conservative therapy consisting of daily custom foot orthoses, progressive posterior tibial tendon eccentric training (twice weekly), daily short-foot exercises, and calf stretching, followed by evaluation at baseline, week 6, and week 12 follow-up.
Behavioral: Custom Foot Orthoses and Exercise Therapy
Overhead athletes aged 18-35 years who have undergone unilateral medial ulnar collateral ligament anterior bundle (mUCLAB) reconstruction and returned to training or competition. Participants complete an 8-week progressive isokinetic strength training program targeting the forearm flexor-pronator mass under blood flow restriction twice weekly.
Other: Forearm Blood Flow Restriction Training
An 8-week progressive Nordic hamstring curl exercise protocol performed twice weekly. Following initial technique instruction, participants perform progressive eccentric hamstring curls starting from 3 sets of 6 repetitions in weeks 1-2 and progressing to 3 sets of 12 repetitions in weeks 7-8.
A 6-week conservative program consisting of: (1) Wearing custom-molded foot orthoses daily during ambulatory activities; (2) Progressive eccentric posterior tibial tendon strengthening on an isokinetic dynamometer (twice a week, 3 sets of 15 repetitions); (3) Progressive short-foot exercises (30-40 repetitions daily); and (4) Gastrocnemius and soleus stretching.
An 8-week progressive isokinetic strength training program targeting the forearm flexor-pronator muscles (pronator teres, flexor carpi ulnaris, brachialis) and handgrip, performed twice weekly. Exercises are performed under pneumatic blood flow restriction set at 70% limb occlusion pressure (LOP) of the brachial artery, at 40-60% of maximal voluntary isometric contraction (4 sets of 20 repetitions per muscle group).
Longitudinal Muscle Displacement of the Biceps Femoris Long Head (Arm 1)
Longitudinal muscle displacement in millimeters of the middle biceps femoris long head (BFlh) tracked using ultrasound speckle tracking during a 20°/s maximal pain-free isokinetic eccentric knee flexion task.
Time frame: Baseline and Week 8 post-intervention
Posterior Tibial Tendon Dynamic Torsion, Tendon Displacement, and Shear Wave Velocity (Arm 2)
PTT dynamic torsion and displacement quantified using cross-sectional ultrasound speckle tracking during maximal isometric foot adduction, and tendon mechanical properties evaluated as mean shear wave velocity using shear wave elastography at proximal and distal tibialis posterior tendon.
Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)
Regional Strain of the Reconstructed mUCLAB Graft (Arm 3)
Regional engineering strain along the longitudinal axis of the reconstructed medial ulnar collateral ligament anterior bundle (mUCLAB) across proximal, middle, and distal regions, quantified using ultrasound speckle tracking under a standardized 5 N·m dynamic valgus torque.
Time frame: Baseline and Week 8 post-intervention
Eccentric Knee Flexor Peak Torque (Arm 1)
Maximal eccentric knee flexor peak torque (N·m) evaluated at 20°/s isokinetic velocity using an isokinetic dynamometer (Biodex Medical Systems, NY, USA) across a range of 90° to 0° knee flexion.
Time frame: Baseline and Week 8 post-intervention
Functional Assessment Scale for Acute Hamstring Injuries (FASH) Score (Arm 1)
Self-reported hamstring injury symptoms and physical function assessed using the FASH questionnaire. The score ranges from 0 to 100, where higher scores indicate superior hamstring function and less severity of symptoms.
Time frame: Baseline and Week 8 post-intervention
Long Head of Biceps Femoris Muscle Shear Wave Velocity (Arm 1)
Resting muscle stiffness quantified as shear wave velocity (m/s) at the suspected BFlh injury site and adjacent regions (1 cm proximal and distal) using shear wave elastography with a curved transducer.
Time frame: Baseline and Week 8 post-intervention
Intramuscular Power Doppler Vascularity Grade (Arm 1)
Vascularity around the suspected BFlh injury site evaluated using power Doppler ultrasonography on a 4-point ordinal scale: Grade 0 (no flow or 1 color pixel), Grade 1 (2-3 color pixels or 1 vessel), Grade 2 (2-3 vessels), and Grade 3 (\>3 vessels).
Time frame: Baseline and Week 8 post-intervention
Intramuscular Scar Gap Size During Isometric Contraction (Arm 1)
Measurement of the presence and gap size (mm) around the intramuscular scar tissue visualized in the longitudinal view under dynamic B-mode ultrasound during maximal voluntary isometric knee flexion at 30°.
Time frame: Baseline and Week 8 post-intervention
Hamstring Flexibility (Arm 1)
Hamstring flexibility evaluated via the active knee extension test in a supine 90-90 hip-knee position, recorded as the final achieved knee extension angle (in degrees, °) measured with a goniometer.
Time frame: Baseline and Week 8 post-intervention
Revised Foot Function Index (FFI-R) (Arm 2)
Patient-reported foot symptoms, pain, disability, and activity limitation evaluated via the Revised Foot Function Index (FFI-R), scored from 0 to 100 with higher scores reflecting greater impairment.
Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)
Musculoskeletal Health Questionnaire (MSK-HQ) Score (Arm 2)
Overall musculoskeletal health status and quality of life assessed via the MSK-HQ. The total score ranges from 0 to 56, with higher scores representing better musculoskeletal health.
Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)
Visual Analog Scale (Arm 2)
Patient self-reported foot pain intensity measured on a 100-mm Visual Analog Scale (VAS), where 0 mm indicates no pain and 100 mm indicates worst imaginable pain.
Time frame: Baseline, each treatment session before/after, Week 6, and Week 12 (follow-up)
Single-Leg Heel-Rise Test (Arm 2)
Functional performance of the posterior tibial muscle evaluated via the single-leg heel-rise test, documenting heel elevation height (cm) and the presence of heel inversion.
Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)
Maximal Voluntary Isometric Foot Inversion Torque (Arm 2)
Maximal voluntary isometric foot inversion peak torque (N·m) measured using an isokinetic dynamometer (Biodex Medical Systems, NY, USA) with simultaneous electromyography monitoring to ensure isolation of the tibialis posterior.
Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)
Five-Minute Walk Test (Arm 2)
Functional walking capacity evaluated as the total distance walked (in meters) within 5 minutes.
Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)
Y-Balance Test (Arm 2)
Dynamic standing balance evaluated via the Y-balance test with the stance leg, recording foot excursion (in cm) during movement of the reach leg.
Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)
Countermovement Push-Up (CMPU) Maximal Vertical Force (Arm 3)
Upper-extremity explosive strength and power assessed as maximal vertical ground reaction force (in Newtons) recorded on a portable force plate during the CMPU test.
Time frame: Baseline and Week 8 post-intervention
Disabilities of the Arm, Shoulder, and Hand (DASH) Score (Arm 3)
Subjective upper-extremity functional recovery and disability assessed using the Taiwan version of the DASH questionnaire, scored from 0 to 100 (higher scores indicate greater disability and symptom severity).
Time frame: Baseline and Week 8 post-intervention
Regional Young's Modulus of Reconstructed mUCLAB (Arm 3)
Tissue elasticity and stiffness (in kPa) of the reconstructed mUCLAB measured at the proximal, middle, and distal regions using shear wave elastography.
Time frame: Baseline and Week 8 post-intervention
Shoulder and Elbow Maximal Voluntary Isometric Muscle Strength (Arm 3)
Maximal voluntary isometric contraction strength (in Newtons or kilograms) of the shoulder and elbow muscle groups measured using a hand-held dynamometer (microFET®2, Hoogan Health Industries, West Jordan, UT, USA).
Time frame: Baseline and Week 8 post-intervention
Shoulder and Elbow Active Range of Motion (Arm 3)
Active range of motion (in degrees, °) of the shoulder (flexion, internal/external rotation) and elbow (flexion, extension, pronation, supination) measured using a standard universal goniometer.
Time frame: Baseline and Week 8 post-intervention
Start is estimated for Nov 2026; primary completion for Jul 2028, 20 months later.
Of 89 non-industry interventional studies with no phase under Flatfoot, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 15. This study's planned 20 months is above that.
Counting every sponsor, half of 89 studies reached it within 7 months; a quarter within 2 and three quarters within 15.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Taiwan University Hospital →